The “Health Development Plan” also predicts that more than 20,000 jobs will be created by the end of this decade
The Health Development Plan (PDS) of the Portuguese Health Cluster (HCP) proposes to triple the current investment in research and development (R&D) to reach 1 billion euros per year by 2030 and create 20,000 jobs.
The “Healthy Development Plan 2021-2030 (PDS)” released this week sets 1 billion euros a year as the “2030 annual investment target”, of which two-thirds will come from the commercial sector and one-third from the non-commercial sector”- “It means multiplying the current value by three”, bringing Portugal closer to the European average.
HCP pointed out in a statement that PDS is also betting on the creation of qualified and highly qualified employment opportunities, proposing to reach the industrial employment level of 35,000 workers by 2030, which means that another 20,000 jobs will be created by the end of 2030. ten years.
Another “big goal” is to achieve an industry-based gross value added (GVA) of approximately 2.6 billion euros per year and an annual export value of 5 billion euros. ten years. “
According to HCP, PDS is “built on the appreciation of knowledge and a leap in R&D investment”, and it was selected as “one of its structural goals.”
He insisted that: “As a relevant institution in this industry, HCP believes that it is necessary to formulate an action plan to clearly understand the strategic importance of a healthy ecosystem and promote its attractiveness and competitiveness in Europe and the world. .”.
In this sense, the plan “outlined specific guidelines in key areas that will bring more competitiveness to the health sector and thus more vitality to the national economy.”
In order to achieve these goals, the Portuguese health industry cluster stated that it is necessary to “invest 2.535 billion to 3.5 billion euros in six betting areas: innovative medicines, “smart health”, essential medicines, medical equipment, clinical trials and knowledge appreciation”.
According to Joaquim Cunha, “At present, people’s awareness of the importance and centrality of health in collective development has been greatly enhanced, and a series of related financial resources have been provided in the PRR. [Plano de Recuperação e Resiliência] e no Portugal2030”.
He added: “The health development plan is a missing strategic tool.”
With the pandemic crisis “showing the centrality of health and the decisive role of its value chain in social and economic development”, HCP intends to “strengthen the “health + value” agreement that has been concluded with the Ministry of Economic Affairs” with PDS. The premise is to make a series of key investments in the next few years, and to achieve “grand goals” by the end of this century.
“Various factors have severely limited the capacity of domestic investment and the attractiveness of foreign direct investment. [investimento direto estrangeiro] In Portugal’s healthcare products industry, the background costs are high and the national market is small; the lack of connection between industrial “participants” and knowledge centers; among the major players in Pharma and MedTech, national recognition is not high; slow bureaucracy And administrative procedures”, the health team explained.
While taking these constraints into consideration, PDS “encourages the renewal and strengthening of the “health + value” agreement, focusing on mobilization, structured and well-designed response measures.”
“In the harmonious and balanced combination of public policy, collective action, and the most important business project (ie consortium), this can be called Pact 5.0-consistent with PRR and the multi-year financial framework 2021-2027 (PT2030). Under the promise of healthy development,” he insisted.